UK: Medical Device Manufacturers Risk Facing New Unannounced Inspections

Last Updated: 6 August 2012
Article by Nicolas Zhu

On 18 June 2012, the State Food and Drug Administration ("SFDA") issued new regulations entitled "Interim Working Procedure of Unannounced Inspections over Manufacturing Enterprises of Medical Devices" ("Procedure"). Being the first framework regulation governing unannounced inspections for medical device manufacturers, it will undoubtedly have an important impact on all companies producing medical devices.

History review

The first unannounced inspection regime started in 2006 but this only related to pharmaceutical manufacturers, and not companies producing medical devices. The SFDA published an unannounced inspection provision regarding good manufacturing practices ("GMP") for pharmaceutical products entitled "the Interim Provision on Unannounced Inspections over GMP of Pharmaceuticals" (the "Provision"), which came into effect on 24 April 2006.

Under the Provision, all pharmaceutical manufacturers in China have faced the possibility of an unexpected inspection by the department of SFDA, (usually the Centre for Certification of Drugs) in order to check whether their manufacturing process satisfies GMP requirements. The confidentiality of such inspections is strictly controlled and the target of any inspection is decided by the SFDA at national level. The local FDA is only given information about the inspection on the day before the inspection.

Although the Provision only applies to pharmaceutical manufacturers, in practice, the local FDA also conducts unannounced inspections on pharmaceutical trading companies. Local FDAs consider that as the procedure under the Provision has been implemented for several years and is well established, it can be applied also to pharmaceutical trading companies.

However, the regulations are not applicable to companies producing medical devices and so the local FDA is not obliged to conduct such inspections based on the Provision.

New Unannounced Inspections of Medical Device Manufacturers

The newly published Procedure relies on the "Measures for Supervision and Administration of Medical Device Production", effective as of 20 July 2004, and the "Interim Provision on the Daily Supervision Management of Medical Device Manufacturing", effective as of 19 January 2006. The implementing Procedure provides a legal basis for the conduct of inspections on medical device manufacturers and so we would now expect to see a rise in the number of these inspections that take place.

The above mentioned framework of legislative provisions broadly set out the circumstances under which the inspections shall be carried out. They also impose an "enterprise credit system", which is a series of files recording all of the supervision results conducted on manufacturers. This enterprise credit system is used as evidence to launch any unannounced inspection.

In fact, such Procedure had been the subject of discussion internally in SFDA for some time, aiming to standardise the inspection process in this area. Manufacturers of all types of medical devices may be subject to such inspections, including but not limited to sterile medical devices, implantable medical devices, and in vitro diagnostics.

1. Inspection team

The inspection team is usually fielded by the SFDA or provincial FDA and is made up of at least two officers. An expert team may be involved if necessary.

2. Inspected party

The following medical device manufacturers may be subject to an unannounced inspection under the Procedure:

a) An enterprise which is suspected of illegal actions;
b) An enterprise which has a serious product quality accident;
c) An enterprise whose products are proven to be of unfit quality in a spot check by the local FDA
d) An enterprise which lacks a quality management system;
e) An enterprise whose credit report shows that it does not have a history of good record keeping;
f) Other reasons may also be considered by the local FDA.

3. Inspection method

The inspection method includes three steps: (a) inspection preparation, (b) on-site inspection, and (c) measures to be taken according to the inspection result. Three inspection sheets need to be completed during the procedure. These sheets enable the medical device manufacturers to understand the exact reason(s) for any inspection and the concurrent results.

The three sheets include the information about the inspected party, the members of the inspection team and the reason and target of the inspection. The names of the inspection team members, all other participating persons as well as the authorities who have organised such inspections are recorded on these sheets. The inspected party is also requested to sign the sheets to acknowledge all the information of the inspection.

If any violation is found during the inspection, the inspection team can hand over the case directly to the local FDA in charge of this inspected party for them to pursue an administrative liability action.

During the inspection process, the inspected party may appeal, explain and/or correct the discovered issues immediately. Although these issues will still be recorded on the inspection sheet, the inspected party may reduce the risk that the inspection team directly refers them to the local FDA to investigate matters further.

4. Basis of such inspection

The inspection is mainly aimed to check whether a medical device manufacturer is complying with the underlying legislative Measures mentioned above, particularly for the purpose of eliminating the following issues:

  • products which fail to meet the national standards, industry standards or registered product standards;
  • companies operating outside the permitted scope in the manufacturing license;
  • companies operating below the required production standards;
  • violations of labeling and packaging requirements;
  • failure to set up a system of follow-up quality supervision and monitoring of adverse incidents;
  • violations of regulations with respect to advertising medical devices; and
  • enterprise manufacturing medical devices without having complied with registration formalities.

5. Consequence of the inspection

A final inspection report will be submitted to the FDA presiding over the unannounced inspection. During or after the inspection, the inspecting team may hand over the case to the local FDA for them to pursue the administrative liability sanction.

According to the framework legislation, this liability sanction may include a revocation of the business license, a monetary penalty up to five times the value of any illegal income or an order suspending business activities.

It is still unclear whether the SFDA or the provincial FDA will rely on these new provisions to inspect medical device trading enterprises in China also. According to the local practice of unannounced inspections for pharmaceutical companies, however, such a possibility should be anticipated . Some local FDA has orally confirmed with us that this does not seem likely for the time being, especially since the procedure has not yet been completely implemented at the same level as the regime for the inspection of pharmaceuticals.


If a company receives an adverse result from such an inspection, it will not only receive a punishment but its credit record with the authorities will also be affected. Once the credit record is affected, the enterprise risks receiving further inspections. All medical device companies must therefore pay serious attention to their compliance with the applicable rules to avoid the risk of being inspected. If a company is inspected, it is recommended to keep an internal record of that inspection so that it can maintain control and supervision over such inspection matters.

Any inspection records would also be useful evidence if the company is the subject of an acquisition. Being able to check whether or not a target company has been subject to an inspection, as well as its inspection record, will help to identify any potential problems in a target company.  

This article was written for Law-Now, CMS Cameron McKenna's free online information service. To register for Law-Now, please go to

Law-Now information is for general purposes and guidance only. The information and opinions expressed in all Law-Now articles are not necessarily comprehensive and do not purport to give professional or legal advice. All Law-Now information relates to circumstances prevailing at the date of its original publication and may not have been updated to reflect subsequent developments.

The original publication date for this article was 30/07/2012.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.